Format

Send to

Choose Destination
Lancet Neurol. 2008 Apr;7(4):327-40. doi: 10.1016/S1474-4422(08)70060-7.

Paraneoplastic syndromes of the CNS.

Author information

1
Division of Neuro-oncology, Department of Neurology, University of Pennsylvania, Philadelphia 19104, USA. josep.dalmau@uphs.upenn.edu

Abstract

Major advances in the management of paraneoplastic neurologic disorders (PND) include the detection of new antineuronal antibodies, the improved characterisation of known syndromes, the discovery of new syndromes, and the use of CT and PET to reveal the associated tumours at an early stage. In addition, the definition of useful clinical criteria has facilitated the early recognition and treatment of these disorders. In this article, we review some classic concepts about PND and recent clinical and immunological developments, focusing on paraneoplastic cerebellar degeneration, opsoclonus-myoclonus, and encephalitides affecting the limbic system.

PMID:
18339348
PMCID:
PMC2367117
DOI:
10.1016/S1474-4422(08)70060-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center